These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36602648)

  • 1. Self-esteem in stabilized individuals with chronic schizophrenia: association with residual symptoms and cognitive functioning.
    Hofer A; Biedermann F; Kaufmann A; Kemmler G; Pfaffenberger NM; Yalcin-Siedentopf N
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1737-1746. PubMed ID: 36602648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metacognitive awareness of cognitive problems in schizophrenia: exploring the role of symptoms and self-esteem.
    Cella M; Swan S; Medin E; Reeder C; Wykes T
    Psychol Med; 2014 Feb; 44(3):469-76. PubMed ID: 23734941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and cognitive factors affecting psychosocial functioning in remitted patients with bipolar disorder.
    Konstantakopoulos G; Ioannidi N; Typaldou M; Sakkas D; Oulis P
    Psychiatriki; 2016; 27(3):182-191. PubMed ID: 27837572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premorbid Social Functioning and Affective Symptoms Predict Subjective Outcome Among Outpatients With Schizophrenia.
    Hoertnagl CM; Kaufmann A; Yalcin-Siedentopf N; Pfaffenberger NM; Frajo-Apor B; Pardeller S; Kemmler G; Hofer A
    Front Psychiatry; 2020; 11():570857. PubMed ID: 33192696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic remission and neurocognitive functioning in patients with schizophrenia.
    Hofer A; Bodner T; Kaufmann A; Kemmler G; Mattarei U; Pfaffenberger NM; Rettenbacher MA; Trebo E; Yalcin N; Fleischhacker WW
    Psychol Med; 2011 Oct; 41(10):2131-9. PubMed ID: 21426601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community dysfunction in schizophrenia: rate-limiting factors.
    Bozikas VP; Kosmidis MH; Kafantari A; Gamvrula K; Vasiliadou E; Petrikis P; Fokas K; Karavatos A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):463-70. PubMed ID: 16442195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlating cognitive functions to symptom domains and insight in Egyptian patients with schizophrenia.
    Khalil AH; El-Meguid MA; Bastawy M; Rabei S; Ali R; Abd Elmoneam MHE
    Int J Soc Psychiatry; 2020 May; 66(3):240-248. PubMed ID: 31928181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and clinical predictors of functional capacity in patients with first episode schizophrenia.
    Vesterager L; Christensen TØ; Olsen BB; Krarup G; Melau M; Forchhammer HB; Nordentoft M
    Schizophr Res; 2012 Nov; 141(2-3):251-6. PubMed ID: 23017825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does cognition predict community function only in schizophrenia?: a study of schizophrenia patients, bipolar affective disorder patients, and community control subjects.
    Laes JR; Sponheim SR
    Schizophr Res; 2006 May; 84(1):121-31. PubMed ID: 16443348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive performance in children aged 9-12 years who present putative antecedents of schizophrenia.
    Cullen AE; Dickson H; West SA; Morris RG; Mould GL; Hodgins S; Murray RM; Laurens KR
    Schizophr Res; 2010 Aug; 121(1-3):15-23. PubMed ID: 20580530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive correlates of verbal memory and verbal fluency in schizophrenia, and differential effects of various clinical symptoms between male and female patients.
    Brébion G; Villalta-Gil V; Autonell J; Cervilla J; Dolz M; Foix A; Haro JM; Usall J; Vilaplana M; Ochoa S
    Schizophr Res; 2013 Jun; 147(1):81-85. PubMed ID: 23578747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verbal memory, negative symptomatology and prediction of psychosocial functioning in schizophrenia.
    Puig O; Penadés R; Gastó C; Catalán R; Torres A; Salamero M
    Psychiatry Res; 2008 Feb; 158(1):11-7. PubMed ID: 18001844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders.
    Potvin S; Aubin G; Stip E
    Eur Arch Psychiatry Clin Neurosci; 2015 Mar; 265(2):147-54. PubMed ID: 24925606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premorbid intellectual ability in schizophrenia influence family appraisal related to cognitive impairments: a cross-sectional study on cognitive impairment and family assessments.
    Ebina K; Matsui M; Higuchi Y; Suzuki M
    BMC Psychiatry; 2022 Mar; 22(1):227. PubMed ID: 35361170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-assisted cognitive remediation therapy: cognition, self-esteem and quality of life in schizophrenia.
    Garrido G; Barrios M; Penadés R; Enríquez M; Garolera M; Aragay N; Pajares M; Vallès V; Delgado L; Alberni J; Faixa C; Vendrell JM
    Schizophr Res; 2013 Nov; 150(2-3):563-9. PubMed ID: 24035402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive performance, psychopathology and social functioning in individuals at high risk for schizophrenia or psychotic bipolar disorder.
    Gkintoni E; Pallis EG; Bitsios P; Giakoumaki SG
    J Affect Disord; 2017 Jan; 208():512-520. PubMed ID: 27810272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outcome prediction model for schizophrenia: A structural equation modelling approach.
    Ojeda N; Sánchez P; Gómez-Gastiasoro A; Peña J; Elizagárate E; Ezcurra J; Ibarretxe-Bilbao N; Gutiérrez M
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(4):232-241. PubMed ID: 30975597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.